This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Speaking Engagement

Time to act: Building a pharmaceutical framework fit for rare diseases

February 8, 2023

European Parliament, Brussels, Belgium

Cells under microscope

Milan Ferguson presents during the panel session titled ” The value of newborn screening: An SMA case study.”

For more information on this event, click here.

Related capabilities

Share

Pricing & Market Access
Infographics

Rare disease PMA trends in France: Price achieved vs. disease prevalence

In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.
Pricing & Market Access
Infographics

Rare disease PMA trends in France: Price achieved vs. type of clinical comparator arm

As part of the CRA Life Sciences series on leveraging RADAR, our orphan drug data repository, we analyzed the relationship between annual list prices achieved

Explore our thinking

Life Sciences
CRA Hosted Event

January 13, 2026

San Francisco, CA

What Happens if U.S. Pharmaceutical Prices Become the World’s Benchmark?

The U.S. Most Favored Nation (MFN) Executive Order could upend global drug pricing as we know it. Some manufacturers are now vowing to launch only at U.S....